Home Top Movers Why Enochian Biosciences, Inc. (ENOB) stock Skyrocketed today?

Why Enochian Biosciences, Inc. (ENOB) stock Skyrocketed today?

Shares of the Enochian Biosciences, Inc. (ENOB) stock had skyrocketed today on June 14, 2021, following the announcement of FDA acceptance of Pre-IND request for a potential functional cure or treatment of HIV by Enochian Biosciences. ENOB stock price saw an uptrend of  165.76% to reach $11.72 a share at the time of this writing. ENOB stock went up by 0.46% at the previous closing. Let’s deeply look at the recent events of ENOB stock.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Acceptance of Pre-IND request

Dr. Serhat Gumrukçu, who is the co-founder of Enochian BioSciences and Director of Seraph Research Institute had submitted the request forPre-IND acceptance. The request was based on results taken from the 54-year-old patient suffering from HIV. The patient didn’t suppress the virus with antiviral activity. The patient then showed the 255-day control when treated with Natural Killer (NK) and Gamma Delta T-cells (GDT) which were collected from the other person. In the 255 days, the patient was not treated with any antiviral treatment.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

The innovative cell theory can play an important part in achieving the functional cure against HIV as it would allow individuals suffering from HIV to stop antiviral treatment for long periods. Dr. Mark Dybul said that it is important to evaluate this innovative approach in the larger population for an extended period in order to deeply test this novel NK-GDT treatment.

Previous Development

On March 25, 2021, Enochian BioSciences in collaboration with Seraph Research Institute(RSI)  announced the complete remission of a 36-year-old patient who was suffering from recurrent glioblastoma for a tenure of 15 months. The patient was treated with natural killer (NK) and dendritic cells (DC) by SRI and the dendritic cells were taken from a relative of the patient who had a partial genetic mismatch.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

ENOB stock is hot among investors so far after the announcement of acceptance of Pre-IND by the FDA and the per-share price has increased more than double as a result of this announcement. The innovative cellular way of treatment could be the hope for those individuals who are tired of conventional antiviral treatments which also result in many side effects.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

Related News

Veoneer Inc. (VNE) stock shows massive gains during pre-market. What’s driving it high?

Veoneer Inc. (NASDAQ: VNE) stock decline by 1.82% at the last close whereas the VNE stock price gains by 55.19% in the pre-market trading...

AnPac Bio-Medical Sciences Inc. (ANPC) stock soars during pre-market. Here’s what you should know?

AnPac Bio-Medical Sciences Inc. (NASDAQ: ANPC) stock declined by 4.98% at last close however the ANPC stock price gains by 6.96% in the pre-market...

Endeavour Silver Corp. (EXK) stock surged during pre-market trading. Here’s what you should know?

Endeavour Silver Corp. (NASDAQ: EXK) stock declined by 4.97% at the last close whereas the EXK stock price gains by 3.56% in the pre-market...

Here is why Amneal Pharmaceuticals Inc (AMRX) stock soared on Monday?

Amneal Pharmaceuticals Inc. (AMRX) shares rose 7.18% in after-hours on Monday, July 19, 2021, and closed at $4.63 per share. Earlier in the morning,...

Why Applied DNA Sciences Inc. (APDN) stock had a bad Friday?

Applied DNA Sciences Inc. (APDN) shares fell 5.27% in after-hours on Friday, July 16, 2021, at $5.03 per share. Earlier, APDN's stock lost 2.93%...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam